6533b7ddfe1ef96bd1273bfe
RESEARCH PRODUCT
Preclinical characterization of IMAB362-vcMMAE, an anti-CLDN18.2 antibody–drug conjugate
R. Mitnacht-krausUgur SahinÖZlem TüreciM. Kreuzbergsubject
0301 basic medicineAntibody-drug conjugatebiologybusiness.industryHematologyPharmacology03 medical and health sciences030104 developmental biology0302 clinical medicineOncology030220 oncology & carcinogenesisbiology.proteinMedicineAntibodybusinessIMAB362year | journal | country | edition | language |
---|---|---|---|---|
2017-09-01 | Annals of Oncology |